Replies to post #205538 on Biotech Values

[RNsidersbuying]

bustoutbio's VSTM, DNAI, MIRN now all trading well below 1/2 cash and that's including their expected burns for Q3. Can't remember 3 bio's at one time trading so beat up like this. I've been adding in all 3.

[DewDiligence]

(ABT)—STJ trial comparing PCI imaging technologies shows OCT stacks up well against angiography and IVUS (the current standards of care):

http://finance.yahoo.com/news/ilumien-iii-clinical-trial-results-132700311.html